Publications (69) MARCOS GARCIA FUENTES publications

2024

  1. Self-assembled peptide/polymer hybrid nanoplatform for cancer immunostimulating therapies

    Drug Delivery and Translational Research, Vol. 14, Núm. 2, pp. 455-473

2023

  1. Matrices Activadas con ARNm como Sistema para la Regeneración de Cartílago Articular

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  2. Matrices Activated with Messenger RNA

    Journal of Functional Biomaterials, Vol. 14, Núm. 1

  3. Nanoplataformas híbridas péptido/polímero comoinmunoestimulantes frente al cáncer

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  4. Optimización del aislamiento de partículas similares al virus del Ébola

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  5. Polifosfacenos: la promesa de los biomateriales enformulación farmacéutica

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  6. Viral protein nanoparticles (Part 1): Pharmaceutical characteristics

    European Journal of Pharmaceutical Sciences, Vol. 187

  7. Viral protein-based nanoparticles (part 2): Pharmaceutical applications

    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Vol. 189, pp. 106558

2021

  1. Delivery of transcription factors as modulators of cell differentiation

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 426-444

  2. Purification of hollow sporopollenin microcapsules from sunflower and chamomile pollen grains

    Polymers, Vol. 13, Núm. 13

2020

  1. Extracellular matrix mechanics regulate transfection and SOX9-directed differentiation of mesenchymal stem cells

    Acta Biomaterialia, Vol. 110, pp. 153-163

  2. Gene Therapy for the Treatment of Chronic Wounds

    Therapeutic Dressings and Wound Healing Applications, pp. 209-234

  3. Polyphosphazenes for the delivery of biopharmaceuticals

    Journal of Applied Polymer Science, Vol. 137, Núm. 25

  4. Preparation and characterization of lamotrigine containing nanocapsules for nasal administration

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 153, pp. 177-186

  5. Suppression of cancer stem cells

    Biomaterials for Cancer Therapeutics (Second Edition) (Woodhead Publishing), pp. 398-365

  6. mRNA-activated matrices encoding transcription factors as primers of cell differentiation in tissue engineering

    Biomaterials, Vol. 247

2019

  1. Advances in Drug Delivery Strategies for Microbial Healthcare Products

    Environmental Chemistry for a Sustainable World, pp. 1-38

  2. Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells

    Journal of Controlled Release, Vol. 295, pp. 60-73

  3. Intracellular delivery of an antibody targeting gasdermin-b reduces her2 breast cancer aggressiveness

    Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4846-4858

  4. Self-assembled hyaluronan nanocapsules for the intracellular delivery of anticancer drugs

    Scientific Reports, Vol. 9, Núm. 1